11th Jul 2023 Plain Language Summary: the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
23rd May 2023 Plain Language Summary: the MAIA study, daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma
23rd Feb 2023 A plain language summary of daratumumab plus lenalidomide / bortezomib / dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN study